Khoury v. Thota

CourtCourt of Appeals for the Fifth Circuit
DecidedSeptember 1, 2021
Docket20-20578
StatusUnpublished

This text of Khoury v. Thota (Khoury v. Thota) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Khoury v. Thota, (5th Cir. 2021).

Opinion

Case: 20-20578 Document: 00516001014 Page: 1 Date Filed: 09/01/2021

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

FILED No. 20-20578 September 1, 2021 Lyle W. Cayce Clerk Medical Doctor Nabil T. Khoury,

Plaintiff—Appellant,

versus

Medical Doctor Archana Thota; Does 1 through 10, inclusive; Roes 11 through 20, inclusive; Apollo Healthcare at Willowbrook, L.L.C.; Willowbrook Med Properties, L.L.C.,

Defendants—Appellees.

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:19-CV-4806

Before Higginbotham, Willett, and Duncan, Circuit Judges. Per Curiam:* In this securities fraud case, Dr. Nabil Khoury appeals the dismissal of his complaint under Rule 12(b)(6) and the Private Securities Litigation Reform Act (PSLRA), 15 U.S.C. § 78u-4. He also appeals the district court’s

* Pursuant to 5th Circuit Rule 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Circuit Rule 47.5.4. Case: 20-20578 Document: 00516001014 Page: 2 Date Filed: 09/01/2021

No. 20-20578

denial of leave to amend his complaint. We conclude that the district court correctly determined that (1) Khoury failed to satisfy the requirements for pleading securities fraud, and (2) Khoury’s request for leave to amend did not demonstrate how he would cure the defects in his complaint. Accordingly, we AFFIRM. I In September 2014, Dr. Nabil Khoury attended a presentation by Dr. Arcana Thota. Thota sought investors for her “premier” nursing facility that offered “resort-like” care for patients. Thota offered Khoury an opportunity to invest in a nursing home, Apollo, and Willowbrook Med Properties (Willowbrook). For each $10,000 he invested in Apollo, Khoury would obtain a 1% share of Apollo. For each $34,000 he invested in Willowbrook, Khoury would obtain a 1% share of Willowbrook. After Thota assured Khoury that the investment was “low risk” and that “[Thota] had already opened and operated multiple other successful nursing homes on a similar model,” Khoury decided to invest. In October 2014, Khoury signed operating agreements for each of the properties and gave Thota two payments: $50,000 for a 5% share of Apollo, and $68,000 for a 2% share of Willowbrook. A few weeks after his initial investment, and upon Thota’s request, Khoury signed a personal guaranty for Apollo’s bank loan. The following year, in December 2016, Khoury and other investors signed a loan modification agreement for Apollo with the bank. In January 2019, Thota demanded that Khoury invest an additional $50,000 as part of a “cash call” to pay taxes for Apollo. Thota informed Khoury that his failure to make the additional investment would dilute his ownership interest in Apollo while maintaining the same liability to the bank for his personal guaranty. At this point, Khoury realized that something was amiss with his investment. While he paid the $50,000 that Thota demanded, he later

2 Case: 20-20578 Document: 00516001014 Page: 3 Date Filed: 09/01/2021

requested that she return that amount. Thota refused and stated that she had raised $1,000,000 from Apollo’s investors as part of the cash call. Khoury later learned that Thota had only raised $665,000 and decided to investigate Thota and the investment properties. Through conversations with doctors, administrators, and employees of Apollo, Khoury discovered that he had invested in a property where patients lacked proper care, bills were often unpaid, and Medicare regulations were flouted. Khoury attempted to contact Thota and the bank that held his personal guaranty. Thota “effectively disappeared” for months after the cash call but resurfaced after Khoury continued to hound the bank to obtain information about the guaranty. Khoury met with Thota in May 2019 to voice his concerns and asked for a copy of the operating agreements and financial records for the properties. Thota told Khoury to stop contacting the bank, refused to provide Khoury with verification of his ownership in Apollo and Willowbrook, and threatened to default on the loan if he called the bank again. In December 2019, Khoury sued Thota, Apollo Healthcare at Willowbrook, LLC, Willowbrook Med Properties, LLC, and various unknown defendants (collectively “Defendants”). He alleged violations of § 10(b) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b-5, plus various state law claims. Khoury requested a declaratory judgment that he has a 5% and 2% ownership interest in Apollo and Willowbrook, respectively. He also sought damages and injunctive relief. The Defendants moved to dismiss his securities fraud claims under Rule 12(b)(6) for failure to state a claim and his state law claims for improper pleading, untimeliness, or a lack of standing. The Defendants also sought to dismiss his claim for declaratory judgment based on abstention. Khoury’s securities fraud claims were based on four allegations of false representations: (1) Thota’s representation at the investment

3 Case: 20-20578 Document: 00516001014 Page: 4 Date Filed: 09/01/2021

presentation in September 2014 that the investment properties were “low risk” and “premier” facilities; (2) Thota’s successful efforts in October 2014 to convince Khoury to sign a personal guaranty for the Apollo’s bank loan; (3) Thota’s successful efforts in December 2016 to convince Khoury and other investors to sign a loan modification agreement for the bank loan; and (4) Thota’s January 2019 representation that the cash call had raised $1,000,000 rather than $665,000. In addition, Khoury added an additional allegation in his Opposition to the Motion to Dismiss: that in January 2015, Thota failed to provide Khoury with the promised security. The district court dismissed the 2014 allegations as barred by the five- year statute of limitations. 28 U.S.C. § 1658(b)(2). The court dismissed the 2016 and 2019 allegations for failure to satisfy the pleading standard of Rule 9(b) and the PSLRA. The court noted that the 2015 allegation was not raised in the complaint and that it also failed to satisfy the pleading standard. The court dismissed the declaratory judgment as unripe. Finally, the district court dismissed the state law claims since it had disposed of the claims over which it had original jurisdiction. All of these claims were dismissed without prejudice. 1 In dismissing the securities fraud claims, the district court took “judicial notice of a state court proceeding . . . against the defendants by other purported investors in [Apollo and Willowbrook].” Khoury v. Thota, No. 4:19-CV-4806, 2020 WL 6494986, at *5 (S.D. Tex. Oct. 1, 2020) (footnote omitted). The district court stated that “the state court proceeding may reveal additional facts relevant to [Khoury’s] federal securities fraud

1 The district court dismissed with prejudice Khoury’s claims for exemplary damages, attorney fees, and pre- and post-judgment interest, to the extent that he pleaded them as independent causes of action rather than as remedies.

4 Case: 20-20578 Document: 00516001014 Page: 5 Date Filed: 09/01/2021

claims,” so it was “in the interests of justice to dismiss these claims without prejudice.” Id. Khoury appealed the dismissal of his securities fraud claims and argued that the district court erred in not granting him leave to amend his complaint because some of his allegations now risk being time-barred if he were to refile as the district court permitted him to do. II Before considering an appeal’s merits, we must confirm that we have jurisdiction. Casteneda v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Castaneda v. Falcon
166 F.3d 799 (Fifth Circuit, 1999)
Nathenson v. Zonagen Inc.
267 F.3d 400 (Fifth Circuit, 2001)
McKinney v. Irving Independent School District
309 F.3d 308 (Fifth Circuit, 2002)
Goldstein v. MCI Worldcom
340 F.3d 238 (Fifth Circuit, 2003)
Merck & Co. v. Reynolds
559 U.S. 633 (Supreme Court, 2010)
United States v. Wallace & Tiernan Co.
336 U.S. 793 (Supreme Court, 1949)
Rosa Saramiento Moreno v. LG Electronics, USA Inc.
800 F.3d 692 (Fifth Circuit, 2015)
ABC Arbitrage Group v. Tchuruk
291 F.3d 336 (Fifth Circuit, 2002)
Farber v. Louisiana State Board of Medical Examiners
265 F. App'x 152 (Fifth Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Khoury v. Thota, Counsel Stack Legal Research, https://law.counselstack.com/opinion/khoury-v-thota-ca5-2021.